GOLDMAN SACHS GROUP INC - IMMUNIC INC ownership

IMMUNIC INC's ticker is IMUX and the CUSIP is 4525EP101. A total of 63 filers reported holding IMMUNIC INC in Q1 2023. The put-call ratio across all filers is 94.22 and the average weighting 0.1%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of IMMUNIC INC
ValueSharesWeighting
Q1 2023$50,021
+11.2%
33,571
+135.4%
0.00%
Q3 2022$45,000
-51.6%
14,263
-47.0%
0.00%
Q2 2022$93,000
-96.7%
26,891
-89.1%
0.00%
-100.0%
Q1 2022$2,781,000
+64.9%
246,121
+39.7%
0.00%
Q4 2021$1,686,000
+13.5%
176,118
+4.9%
0.00%
Q3 2021$1,485,000
+896.6%
167,877
+1283.9%
0.00%
Q2 2021$149,000
-57.2%
12,131
-46.7%
0.00%
Q4 2020$348,000
-13.4%
22,741
+4.9%
0.00%
Q3 2020$402,00021,6690.00%
Other shareholders
IMMUNIC INC shareholders Q1 2023
NameSharesValueWeighting ↓
Parkman Healthcare Partners LLC 924,087$8,178,0002.07%
Omega Fund Management, LLC 1,788,160$15,825,0001.78%
Ghost Tree Capital, LLC 265,000$2,345,0000.69%
Golden Green, Inc. 87,085$771,0000.60%
Otter Creek Advisors, LLC 100,000$885,0000.47%
Endurant Capital Management LP 185,448$1,641,0000.37%
SPHERA FUNDS MANAGEMENT LTD. 389,812$3,450,0000.29%
RTW INVESTMENTS, LP 1,370,814$12,132,0000.18%
Artal Group S.A. 700,000$6,195,0000.14%
Stonepine Capital Management, LLC 22,409$198,0000.09%
View complete list of IMMUNIC INC shareholders